Global Markets
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
AED • EUR • GBP • USD IBANs   |   CROSS BORDER FX   |   LOCAL CURRENCIES   |   GLOBAL COVERAGE
INRUSD

USD/INR trades flat despite Trump imposing 100% tariffs on pharmaceutical imports

  • The Indian Rupee trades calmly around 88.90 against the US Dollar on Friday.
  • Trump’s announcement of 100% tariffs on pharmaceutical imports could weaken the Indian Rupee.
  • Investors await the US PCE inflation data for August.

The Indian Rupee (INR) trades broadly stable around 88.90 against the US Dollar (USD) on Friday. The USD/INR pair is expected to move higher as United States (US) President Donald Trump has announced fresh tariffs on pharmaceuticals, which will come into effect on October 1.

On Thursday, US President Trump stated through a post on Truth.Social that imports of pharmaceuticals into the US will attract 100% additional duty. Trump didn’t clarify whether countries that have secured a trade deal with Washington will be exempted from new sectoral tariffs.

Overall, the announcement is another damage to India’s export sector that is already facing 50% tariffs on imports into the US, one of the highest among Washington’s trading partners. The impact will be significant on Indian pharmaceutical companies, which exported $3.6 billion worth of healthcare products to the US in 2024, according to Hindustan Times.

The US raised tariffs on imports from India to 50% in early August for buying Oil from Russia, which they called the nation is indirectly funding Moscow’s war with Ukraine.

This week, the announcement of an increase in H-1B visa fees by the US to $100,000 also impacted the Indian Rupee badly.

Meanwhile, Indian Commerce and Trade Minister Piyush Goyal returns to India with his team after trade negotiations with Washington. However, Goyal has not unveiled any material development on bilateral trade talks with the US yet.

On the domestic front, investors await the monetary policy announcement by the Reserve Bank of India (RBI) on Wednesday. Investors expect the RBI to hold its Repo Rate steady at 5.5%.

Daily digest market movers: Investors await US PCE inflation data for August

  • The Indian Rupee has been trading sideways near its all-time high of around 89.10 against the US Dollar (USD) since Wednesday. Sheer strength in the USD/INR pair is also driven by the upbeat US Dollar, which extended its upside further on Thursday after the release of key US data.
  • During the press time, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, trades firmly near its fresh four-week high of around 98.40 posted on Thursday.
  • The US Dollar gains further after the release of the revised US Q2 Gross Domestic Product (GDP) data, which showed that the economy grew at a faster pace of 3.8% on an annualized basis, compared to the preliminary estimate of 3.3%. Also, Durable Goods Orders data for August surprisingly came in positive at 2.9%, while it was expected to decline for the third month in a row.
  • In Friday’s session, investors will pay close attention to the US Personal Consumption Expenditure Price Index (PCE) data for August, which will be published at 12:30 GMT. The impact of the inflation data would be significant on market expectations for the Federal Reserve’s (Fed) monetary policy outlook, as a majority of officials have lately advised caution on further interest rate cuts as risks to inflation have tilted to the upside.
  • Economists expect the US core PCE inflation, which is the Fed’s preferred inflation gauge, to have grown at a moderate pace of 0.2% on a monthly basis against the prior reading of 0.3%, with yearly figures rising steadily by 2.9%.
  • Meanwhile, US President Trump has criticized the Fed, especially Chair Jerome Powell, again, through a post on Truth.Social, for interest rates remaining too high, and has stated that borrowing rates should be around 2%. “If it weren’t for Jerome ’Too Late’ Powell, we would be at 2% right now, and in the process of balancing our budget. The good news is that we’re powering through his incompetence,” Trump wrote.

US Dollar Price Today

The table below shows the percentage change of US Dollar (USD) against listed major currencies today. US Dollar was the strongest against the Canadian Dollar.

 USDEURGBPJPYCADAUDNZDCHF
USD -0.12%-0.07%-0.13%0.05%-0.12%-0.02%-0.08%
EUR0.12% 0.10%0.05%0.22%0.07%0.17%0.06%
GBP0.07%-0.10% 0.06%0.13%0.06%0.08%-0.06%
JPY0.13%-0.05%-0.06% 0.14%-0.03%0.09%-0.10%
CAD-0.05%-0.22%-0.13%-0.14% -0.17%-0.03%-0.19%
AUD0.12%-0.07%-0.06%0.03%0.17% 0.09%-0.04%
NZD0.02%-0.17%-0.08%-0.09%0.03%-0.09% -0.02%
CHF0.08%-0.06%0.06%0.10%0.19%0.04%0.02% 

The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the US Dollar from the left column and move along the horizontal line to the Japanese Yen, the percentage change displayed in the box will represent USD (base)/JPY (quote).

Technical Analysis: USD/INR stays above 20-day EMA

USD/INR turns sideways after posting a fresh all-time high of around 89.10 on Tuesday. The upward-sloping 20-day Exponential Moving Average (EMA) near 88.38 signals more upside in the pair.

The 14-day Relative Strength Index (RSI) stays above 65.00, suggesting a strong bullish momentum.

Looking down, the 20-day EMA will act as key support for the major. On the upside, the round figure of 90.00 would be the key hurdle for the pair.

Register a Revolut Business Account
```

Market Analysis & Disclaimer

The market information, analysis, commentary, forecasts and opinions contained in this publication are provided by Octalas Group Ltd on behalf of Today Markets and Currency Hedger using information and data obtained from sources believed to be reliable. However, Octalas Group Ltd, Today Markets and Currency Hedger do not warrant or guarantee the accuracy, completeness or timeliness of the information presented and accept no responsibility for any loss or damage arising from reliance upon information contained herein, to the extent permitted by applicable law.

Market forecasts, expectations and opinions are based on analysis of available information and a number of assumptions regarding economic, financial, political and market conditions. Such assumptions may prove to be incorrect, and actual market developments may differ materially from those described or anticipated.

Nothing contained in this publication constitutes investment advice, financial advice, a personal recommendation, an offer, solicitation or invitation to buy, sell or otherwise transact in any financial instrument or investment product. The information is provided for general informational and educational purposes only and does not take into account the investment objectives, financial situation, experience or particular circumstances of any individual reader.

Past performance is not indicative of future results. Financial markets, including foreign exchange, commodities, equities, derivatives and other financial instruments, involve risk and prices can move rapidly. Readers should conduct their own independent research and, where appropriate, obtain advice from an appropriately authorised financial professional before making any investment or trading decision.

Where this publication refers to Today Markets, it represents market news, research, analysis and commentary published for informational purposes. Where Currency Hedger is referenced, it represents commentary concerning foreign exchange, currency exposure, international payments and hedging-related topics. References to particular financial instruments, markets, companies, currencies or commodities should not be interpreted as a recommendation to transact in them.

Octalas Group Ltd, Today Markets and Currency Hedger may have commercial interests or relationships with businesses, financial-service providers, technology providers or other market participants mentioned in their publications. Where relevant, such relationships or interests may create potential conflicts of interest. Appropriate measures are intended to be taken to ensure that published analysis and commentary are presented objectively and that commercial considerations do not determine the substance of market analysis.

The views expressed in this publication are those of the author or contributors at the time of publication and may change without notice as market conditions develop. Readers should not assume that any information contained herein has been updated following publication.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button